Cultural Evolution Is the future in our own hands?

Size: px
Start display at page:

Download "Cultural Evolution Is the future in our own hands?"

Transcription

1 Cultural Evolution Is the future in our own hands? Dr Paul Litchfield - Chief Medical Officer, BT Group Laura Collins - Carer and East Belfast ICP member Colette Goldrick - NI Director, APBI Dr Anne Kilgallen - Deputy Chief Medical Officer, DoH NI

2 Dr Paul Litchfield OBE OStJ FRCP FFOM Cultural Evolution a view from industry

3 Markets Technology Competitors Customer expectations Leadership is Critical Skills Attitudes Demographics Employee expectations

4 Appropriate: For a crisis or time sensitive Delivery the priority Well understood processes Low skills and/or trust Creates: Strong sense of hierarchy Clarity of expectation Discipline & compliance Organisational Health Leadership Styles Appropriate: For complex problems Development the priority Behavioural change needed High skills and/or trust Creates: Achievement above expectation Accountability & empowerment Ownership of outcomes

5

6 Culture evolution: Northern Ireland s biomedical innovation potential in a post-brexit world Colette Goldrick, Director ABPI Northern Ireland NICON Conference 28 th June 2016

7 ABPI NI : Who we are and what we do 80 global research-based pharmaceutical member companies, 37 with NI presence Invent, develop and supply 90% prescription medicines used by HSC every day Aim to work with 100% of healthcare stakeholders to improve the health & wealth of Northern Ireland

8

9 Immediate impact of BREXIT on UK life sciences 400 million Interreg Europe funding 6 billion Innovative Medicines Initiative funding 80 billion Horizon 2020 funding

10 Impacts across the life science value chain (Source: Charles Rivers Associates for EFPIA): Basic research: Diminished UK competitiveness in life sciences. Academic researchers and Small and Medium Enterprises SMEs will find it more challenging to collaborate with EU experts. National funding will not replace lost European research funding. Limitations on the free movement of people will impact negatively on both UK and EU academic research and SMEs. Development and licencing of medicines: UK will need to develop its own regulatory framework. No advantage in developing a market authorisation process divergent from EMA. This would cause delays in marketing authorisation (even if the process itself was faster) and additional costs and adversely affect access to medicines. UK and EU will lose some of the benefits of sharing expertise in drug regulatory processes. Manufacturing and trade: We do not find the prospect of the UK being able to negotiate its own trade agreements compelling from a life science perspective. Both UK and EU life sciences industry rely on each other for skilled staff so that a limitation on the free movement of people would have a negative impact on manufacturing. Market Access: UK no longer subject to the EU Transparency Directive. Delay in marketing authorisation could delay access to some medicines.

11 What about NI? We urgently need: Decisive political leadership, recognition of the necessity to retain links with Europe (EEA/ island of Ireland trading block) and active participation in BREXIT talks accordingly Creation of a compelling life sciences implementation plan, linking data, research and rapid access to innovation to improve patient outcomes Birmingham and Manchester have developed theirs in less than a year

12

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Health Innovations in Horizon 2020: the framework programme for research and innovation ( ) Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General

More information

Water, Energy and Environment in the scope of the Circular Economy

Water, Energy and Environment in the scope of the Circular Economy Water, Energy and Environment in the scope of the Circular Economy Maria da Graça Carvalho 11th SDEWES Conference Lisbon 2016 Contents of the Presentation 1. The Circular Economy 2. The Horizon 2020 Program

More information

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters! IMI Revolutionising Europe s Pharmaceutical Industry IMI Matters! Session in the Framework of the Event Joint Technology Initiatives Innovation in Action 4 6 October 2011 European Parliament Brussels Programme

More information

Medical Education Activities

Medical Education Activities Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time

More information

SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry

SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry Introduction SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry SMA Europe is an umbrella body of national Spinal Muscular Atrophy patient representative and research organisations

More information

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018 HDR UK & Digital Innovation Hubs Introduction 22 nd November 2018 Health Data Research UK s vision To create a thriving, high-energy UK-wide network of inter-disciplinary research expertise that will:

More information

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about

More information

FDA Centers of Excellence in Regulatory and Information Sciences

FDA Centers of Excellence in Regulatory and Information Sciences FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in

More information

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association

More information

National Innovation Systems: Implications for Policy and Practice. Dr. James Cunningham Director. Centre for Innovation and Structural Change

National Innovation Systems: Implications for Policy and Practice. Dr. James Cunningham Director. Centre for Innovation and Structural Change National Innovation Systems: Implications for Policy and Practice Dr. James Cunningham Centre for Innovation and Structural Change InterTradeIreland Innovation Conference 2009 9 th June 2009 Overview National

More information

Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive

Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive Opportunities and Challenges in Pharmaceutical Sciences Helen Gordon Chief Executive Challenges we face Drivers for Change in Health Care... and science too Desire for high quality, safe services. The

More information

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,

More information

2. Evidence themes and their importance along the development path

2. Evidence themes and their importance along the development path 1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development

More information

HORIZON Presentation at Manufuture Perspectives on Industrial Technologies in Horizon 2020 and Beyond

HORIZON Presentation at Manufuture Perspectives on Industrial Technologies in Horizon 2020 and Beyond The EU Framework Programme for Research and Innovation HORIZON 2020 Perspectives on Industrial Technologies in Horizon 2020 and Beyond Presentation at Manufuture 2017 Seán O'Reagain Deputy Head of Unit

More information

Expectations around Impact in Horizon 2020

Expectations around Impact in Horizon 2020 Expectations around Impact in Horizon 2020 Dr Ailidh Woodcock European Advisor, UK Research Office Ailidh.Woodcock@bbsrc.ac.uk 16 February 2017 University of Sheffield Agenda Start End Session 10:00 10:10

More information

December Eucomed HTA Position Paper UK support from ABHI

December Eucomed HTA Position Paper UK support from ABHI December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing

More information

ABHI Response to the Kennedy short study on Valuing Innovation

ABHI Response to the Kennedy short study on Valuing Innovation ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.

More information

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data

More information

FUTURE OF MOBILITY. Dr Rupert Wilmouth Head of Sustainable Economy

FUTURE OF MOBILITY. Dr Rupert Wilmouth Head of Sustainable Economy FUTURE OF MOBILITY Dr Rupert Wilmouth Head of Sustainable Economy Government Office for Science Leading GO-Science is Professor Sir Mark Walport, Government Chief Scientific Adviser: Our role is to advise

More information

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry

More information

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD

More information

Written response to the public consultation on the European Commission Green Paper: From

Written response to the public consultation on the European Commission Green Paper: From EABIS THE ACADEMY OF BUSINESS IN SOCIETY POSITION PAPER: THE EUROPEAN UNION S COMMON STRATEGIC FRAMEWORK FOR FUTURE RESEARCH AND INNOVATION FUNDING Written response to the public consultation on the European

More information

Werner Wobbe. Employed at the European Commission, Directorate General Research and Innovation

Werner Wobbe. Employed at the European Commission, Directorate General Research and Innovation Werner Wobbe Employed at the European Commission, Directorate General Research and Innovation Conference Paper, Call to Europe, September 2013 1 The current European Commission policies are guided by the

More information

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences

More information

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution

More information

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Technology and Innovation in the NHS Scottish Health Innovations Ltd Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop

More information

European Charter for Access to Research Infrastructures - DRAFT

European Charter for Access to Research Infrastructures - DRAFT 13 May 2014 European Charter for Access to Research Infrastructures PREAMBLE - DRAFT Research Infrastructures are at the heart of the knowledge triangle of research, education and innovation and therefore

More information

Engaging UK Climate Service Providers a series of workshops in November 2014

Engaging UK Climate Service Providers a series of workshops in November 2014 Engaging UK Climate Service Providers a series of workshops in November 2014 Belfast, London, Edinburgh and Cardiff Four workshops were held during November 2014 to engage organisations (providers, purveyors

More information

Making lives better every day. This is UCB

Making lives better every day. This is UCB Making lives better every day. This is UCB Kristof, living with axial spondyloarthritis Remi, UCB Inspired by patients. Driven by science. We have a shared ambition to transform the lives of people living

More information

Higher Education Contribution to Health Science Innovation

Higher Education Contribution to Health Science Innovation Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28

More information

Telehealth and Digital Technology. Libbe Englander, PhD

Telehealth and Digital Technology. Libbe Englander, PhD Page 1 of 5 Telehealth and Digital Technology Libbe Englander, PhD Editor s note: This is the first in a series of articles by Dr. Englander that will discuss different elements of the value chain where

More information

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on

More information

Compliance for Eucomed: The Medical Technology Industry s s Perspective

Compliance for Eucomed: The Medical Technology Industry s s Perspective Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big

More information

THE NUMBERS OPENING SEPTEMBER BE PART OF IT

THE NUMBERS OPENING SEPTEMBER BE PART OF IT THE NUMBERS 13million new development dedicated to STEM for Plymouth 5.43million funding from the Heart of the South West Local Enterprise Partnership s Growth Deal 2.7million from the Regional Growth

More information

The value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016

The value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016 The value of innovative pharmaceuticals and the potential for Vietnam Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016 PHARMA GROUP Our priority is to ensure that Vietnamese

More information

(Fig.) JPMA Industry Vision 2025

(Fig.) JPMA Industry Vision 2025 2. JPMA Industry Vision 2025 Against the background of the changing environment surrounding the pharmaceutical industry and the future predictions *1, we prepared JPMA Industry Vision 2025 Bringing Innovation

More information

Privacy and the EU GDPR US and UK Privacy Professionals

Privacy and the EU GDPR US and UK Privacy Professionals Privacy and the EU GDPR US and UK Privacy Professionals Independent research conducted by Dimensional Research on behalf of TrustArc US 888.878.7830 EU +44 (0)203.078.6495 www.trustarc.com 2017 TrustArc

More information

Medicines Manufacturing in the UK 2017

Medicines Manufacturing in the UK 2017 Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership

More information

Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... Table Of Content... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D08 - HAI Europe Newsletter (EN)... 7 D01 - HAI Europe leaflet (EN)... 7 D02 - Briefing Papers and statements

More information

EARA Strategic Review

EARA Strategic Review EARA Strategic Review CONTENTS Overview - Establishment - Operations - Achievements Member survey 2017 - Key findings Draft strategy - Vision and mission - Audiences - Five strategy objective - EARA objectives

More information

COST FP9 Position Paper

COST FP9 Position Paper COST FP9 Position Paper 7 June 2017 COST 047/17 Key position points The next European Framework Programme for Research and Innovation should provide sufficient funding for open networks that are selected

More information

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency Enpr EMA European Network of Paediatric Research at the European Medicines Agency Enpr-EMA European Network of Paediatric Research at the European Medicines Agency An agency of the European Union Enpr

More information

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation Funding Position of the European Brain Council (EBC) Introduction The European Brain

More information

Research Patents in Biotech SMEs

Research Patents in Biotech SMEs Research Patents in Biotech SMEs Doorways, Obstacles, Fortifications & Bridges Neil Thomas PhD Director of Intellectual Property, Genetrix Group, Madrid, Spain. Agenda 1. Introduction to Genetrix Definition

More information

S3 IM Medical ++ Technology Partnership MedTech Smart Manufacturing project

S3 IM Medical ++ Technology Partnership MedTech Smart Manufacturing project S3 IM Medical ++ Technology Partnership MedTech Smart Manufacturing project Laurence Minne, Auvergne-Rhône-Alpes Region Marc Pattinson, broker 27/11/18, Bilbao Medical Technologies in the EU Med-tech sectors

More information

Research Development Request - Profile Template. European Commission

Research Development Request - Profile Template. European Commission Research Development Request - Profile Template European Commission Research Development Request Profile The following table can be used as a template for drafting a Research Development Request profile.

More information

The Medical Device Regulation: Transitioning between old and new

The Medical Device Regulation: Transitioning between old and new Association of British Healthcare Industries The Medical Device Regulation: Transitioning between old and new www.abhi.org.uk www.bdia.org.uk Introduction In May 2017, the new Medical Device Regulation

More information

NHS Next Stage Review: Innovation

NHS Next Stage Review: Innovation NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused

More information

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO Brief to the Senate Standing Committee on Social Affairs, Science and Technology Dr. Eliot A. Phillipson President and CEO June 14, 2010 Table of Contents Role of the Canada Foundation for Innovation (CFI)...1

More information

Impact and Innovation in H2020 Proposals and projects

Impact and Innovation in H2020 Proposals and projects Impact and Innovation in H2020 Proposals and projects Dr. Eugene Sweeney Brussels 16th September 2014 Get your ticket to innovation. Roadmap What to look for in a good proposal Managing impact and innovation

More information

Health & Social Care Industrial Innovation

Health & Social Care Industrial Innovation Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging

More information

Education and Culture

Education and Culture Mobility schemes in the Fields of Pharmaceutical and Medical Biotechnologies Marie Curie Actions ENEA, 20 June 2012 Alessandra Luchetti Head of Unit, DG EAC.C3 Outline 1. MCAs in FP7 2. MCAs achievements

More information

Supporting Innovation through Regulation and Science

Supporting Innovation through Regulation and Science Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers

More information

Digital Identity Innovation Canada s Opportunity to Lead the World. Digital ID and Authentication Council of Canada Pre-Budget Submission

Digital Identity Innovation Canada s Opportunity to Lead the World. Digital ID and Authentication Council of Canada Pre-Budget Submission Digital Identity Innovation Canada s Opportunity to Lead the World Digital ID and Authentication Council of Canada Pre-Budget Submission August 4, 2017 Canadian governments, banks, telcos, healthcare providers

More information

4th BioHorizon International Brokerage Event 26 th of June Fare clic per modificare lo stile del titolo

4th BioHorizon International Brokerage Event 26 th of June Fare clic per modificare lo stile del titolo 4th BioHorizon International Brokerage Event 26 th of June 2018 Understanding the Social Sciences and Humanities (SSH) integration in Food topics: Writing successful proposals including SSH aspects @APRE2015

More information

Health Technology Assessment and the European Network for HTA

Health Technology Assessment and the European Network for HTA Health Technology Assessment and the European Network for HTA www.eunethta.eu Marcial Velasco Garrido, Technische Universität Berlin for the European Network for HTA, EUnetHTA Outline What is Health Technology

More information

Biomedical Innovation Has Science Overtaken the System?

Biomedical Innovation Has Science Overtaken the System? Adaptive Pathways for Transformative Medicinal Products. A New Paradigm with the Enhanced Application of Real-World Evidence? ISPOR 20 th Annual European Congress, Glasgow, Scotland Issue Panel 21, Wednesday,

More information

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017 A manifesto for global sustainable health Sustainable Health Symposium Cambridge, UK 25th July 2017 Introduction Across the globe, the health of individuals, their communities and the planet is in crisis

More information

Life Sciences Regulatory

Life Sciences Regulatory Life Sciences Regulatory Pharmaceuticals 2018 2 Life Sciences Regulatory Pharmaceuticals 2018 Top ranked in Chambers and Legal 500 for Life Sciences, pharmaceuticals and biotechnology. Allen & Overy LLP

More information

A Science & Innovation Audit for the West Midlands

A Science & Innovation Audit for the West Midlands A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England

More information

Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market

Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market Executive Consulting Report Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market November 2017 Francois Maignen, Mikel Berdud, Grace Hampson & Paula Lorgelly

More information

European Connected Health Alliance Bringing needs and solutions together for the Future of Health. ECHAlliance Update

European Connected Health Alliance Bringing needs and solutions together for the Future of Health. ECHAlliance Update European Connected Health Alliance Bringing needs and solutions together for the Future of Health ECHAlliance Update Gregor Cuzak, International Ecosystem Coordinator - Gregor@echalliance.com Damian O

More information

EMA Technical Anonymisation Group (TAG)

EMA Technical Anonymisation Group (TAG) EMA Technical Anonymisation Group (TAG) Call for applications Presented by Monica Dias, PhD Policy and Crisis Coordinating Officer An agency of the European Union TAG Anonymisation Background The Agency

More information

NIHR ROADSHOW FOR MEDTECH SMES

NIHR ROADSHOW FOR MEDTECH SMES MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and

More information

ECC ALL ABOUT OUR ORGANISATION The Electronic Communications Committee

ECC ALL ABOUT OUR ORGANISATION The Electronic Communications Committee ECC ALL ABOUT OUR ORGANISATION The Electronic Communications Committee ECC ALL ABOUT OUR ORGANISATION WHO WE ARE The Electronic Communications Committee (ECC) is one of three business committees of the

More information

User Centric Innovation

User Centric Innovation User Centric Innovation Lasse Berntzen Associate Professor Department of Business and Management Vestfold University College Norway About myself Associate Professor at VUC since 2002 Academic background:

More information

Robert Bond Partner, Commercial/IP/IT

Robert Bond Partner, Commercial/IP/IT Using Privacy Impact Assessments Effectively robert.bond@bristows.com Robert Bond Partner, Commercial/IP/IT BA (Hons) Law, Wolverhampton University Qualified as a Solicitor 1979 Qualified as a Notary Public

More information

Executive Summary Industry s Responsibility in Promoting Responsible Development and Use:

Executive Summary Industry s Responsibility in Promoting Responsible Development and Use: Executive Summary Artificial Intelligence (AI) is a suite of technologies capable of learning, reasoning, adapting, and performing tasks in ways inspired by the human mind. With access to data and the

More information

The Intellectual Property, Knowledge Transfer: Perspectives

The Intellectual Property, Knowledge Transfer: Perspectives 1 The Intellectual Property, Knowledge Transfer: Perspectives Salvatore Amico Roxas Intellectual Property & Technology Transfer Unit European Commission - Joint Research Centre Salvatore.amico-roxas@ec.europa.eu

More information

HORIZON The New EU Framework Programme for Dr. Helge Wessel DG Research and Innovation. Research and Innovation

HORIZON The New EU Framework Programme for Dr. Helge Wessel DG Research and Innovation. Research and Innovation HORIZON 2020 The New EU Framework Programme for 2014-2020 Dr. Helge Wessel DG The context: Europe 2020 strategy Objectives of smart, sustainable and inclusive growth Headline targets, including 3% of GDP

More information

Digital Health Startups A FirstWord ExpertViews Dossier Report

Digital Health Startups A FirstWord ExpertViews Dossier Report AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in

More information

Justice Select Committee: Inquiry on EU Data Protection Framework Proposals

Justice Select Committee: Inquiry on EU Data Protection Framework Proposals Justice Select Committee: Inquiry on EU Data Protection Framework Proposals Response by the Wellcome Trust KEY POINTS The Government must make the protection of research one of their priorities in negotiations

More information

Embracing Open Title Innovation Platforms

Embracing Open Title Innovation Platforms Embracing Open Title Innovation Platforms Sub-title Not all the smart people work for us. We need to work with smart people inside and outside the company.» Chesbourgh PLACE PARTNER S LOGO HERE European

More information

Find and analyse the most relevant patents for your research

Find and analyse the most relevant patents for your research Derwent Innovation Find and analyse the most relevant patents for your research Powering the innovation lifecycle from idea to commercialisation The pace of technology change is unprecedented with new

More information

An ecosystem to accelerate the uptake of innovation in materials technology

An ecosystem to accelerate the uptake of innovation in materials technology An ecosystem to accelerate the uptake of innovation in materials technology Report by the High Level Group of EU Member States and Associated Countries on Nanosciences, Nanotechnologies and Advanced Materials

More information

Keywords: Synairgen plc, Southampton, collaboration, spin-out, asthma, COPD

Keywords: Synairgen plc, Southampton, collaboration, spin-out, asthma, COPD Professor Stephen Holgate is a member of the Infection, Inflammation and Repair Division in the University of Southampton School of Medicine. He is a co-founder and non-executive director of Synairgen

More information

Marie Skłodowska- Curie Actions under Horizon2020

Marie Skłodowska- Curie Actions under Horizon2020 Marie Skłodowska- Curie Actions under Horizon2020 Spain, 23-4 May 2013 Paul Harris DG Education & Culture 1 European Commission Outline 1. The Marie Curie Actions (MCA) now & Spanish participation 2. The

More information

COMMISSION RECOMMENDATION. of on access to and preservation of scientific information. {SWD(2012) 221 final} {SWD(2012) 222 final}

COMMISSION RECOMMENDATION. of on access to and preservation of scientific information. {SWD(2012) 221 final} {SWD(2012) 222 final} EUROPEAN COMMISSION Brussels, 17.7.2012 C(2012) 4890 final COMMISSION RECOMMENDATION of 17.7.2012 on access to and preservation of scientific information {SWD(2012) 221 final} {SWD(2012) 222 final} EN

More information

Public Research and Intellectual Property Rights

Public Research and Intellectual Property Rights Workshop on the Management of Intellectual Property Rights from Public Research OECD, Paris, 11 th December 2000 Public Research and Intellectual Property Rights Hugh Cameron PREST, University of Manchester

More information

National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs

National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs Jeff Shuren Director, CDRH Food and Drug Administration Center for Devices and Radiological Health 1 We face a critical public

More information

Supporting Consumers Facilitating Behaviour that Reduces Risky Behaviours. Professor Lynn J. Frewer. Food and Society Group

Supporting Consumers Facilitating Behaviour that Reduces Risky Behaviours. Professor Lynn J. Frewer. Food and Society Group Supporting Consumers Facilitating Behaviour that Reduces Risky Behaviours Professor Lynn J. Frewer Food and Society Group Risky behaviour might mean... Not adopting safe food preparation practices Reducing

More information

An Essential Health and Biomedical R&D Treaty

An Essential Health and Biomedical R&D Treaty An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third

More information

POSITION OF THE NATIONAL RESEARCH COUNCIL OF ITALY (CNR) ON HORIZON 2020

POSITION OF THE NATIONAL RESEARCH COUNCIL OF ITALY (CNR) ON HORIZON 2020 POSITION OF THE NATIONAL RESEARCH COUNCIL OF ITALY (CNR) ON HORIZON 2020 General view CNR- the National Research Council of Italy welcomes the architecture designed by the European Commission for Horizon

More information

IoT in Health and Social Care

IoT in Health and Social Care IoT in Health and Social Care Preserving Privacy: Good Practice Brief NOVEMBER 2017 Produced by Contents Introduction... 3 The DASH Project... 4 Why the Need for Guidelines?... 5 The Guidelines... 6 DASH

More information

knowledge Exchange EXCHANGE YOUR KNOWLEDGE J. MICHAEL HASENKAM - VICE DEAN COLLABORATION WITH SMALL AND MEDIUM SIZED BUSINESSES - WHY AND HOW?

knowledge Exchange EXCHANGE YOUR KNOWLEDGE J. MICHAEL HASENKAM - VICE DEAN COLLABORATION WITH SMALL AND MEDIUM SIZED BUSINESSES - WHY AND HOW? - VICE DEAN COLLABORATION WITH SMALL AND MEDIUM SIZED BUSINESSES - WHY AND HOW? knowledge Exchange RESEARCH, EDUCATION, KNOWLEDGE EXCHANGE, TALENT INTERLINKED ELEMENTS? SOCIETAL DIRECTIONS AND EXPECTATIONS

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint 'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint STOA workshop - European Parliament, 10 January 2019 Presented

More information

Getting the evidence: Using research in policy making

Getting the evidence: Using research in policy making Getting the evidence: Using research in policy making REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 586-I Session 2002-2003: 16 April 2003 LONDON: The Stationery Office 14.00 Two volumes not to be sold

More information

Impact of ICH Q9 and the application of Risk Management

Impact of ICH Q9 and the application of Risk Management Safeguarding public health Impact of ICH Q9 and the application of Risk Management An inspector s perspective on the impact on inspectional approaches and expectations Ian Thrussell Strategy and Development

More information

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The

More information

EARA Strategic Review

EARA Strategic Review EARA Strategic Review CONTENTS Overview - Establishment - Operations - Achievements Draft strategy - Vision and mission - Audiences - Five strategy objective - EARA objectives and actions Page 1 of 10

More information

Societal engagement in Horizon 2020

Societal engagement in Horizon 2020 Societal engagement in Horizon 2020 19 June 2017 Brussels Colombe WARIN European Commission Research Executive Agency B5 - Spreading Excellence, Widening Participation, Science with and for Society Content

More information

Implementation of Directive 2010/63/EU: - the animal welfare perspective

Implementation of Directive 2010/63/EU: - the animal welfare perspective Animal experimentation Implementation of Directive 2010/63/EU: - the animal welfare perspective Kirsty Reid Scientific Officer Research Animals Eurogroup for Animals @KirstyEG4A 21 st May 2015 312 th session

More information

The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges.

The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges. The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges. Dr. Catherine FRADE Strategic Prospective Director AXELPHARM 22nd Annual EuroMeeting March

More information

Health Based Exposure Limits (HBEL) and Q&As

Health Based Exposure Limits (HBEL) and Q&As Health Based Exposure Limits (HBEL) and Q&As The EMA guideline (EMA/CHMP/ CVMP/ SWP/169430/2012) & EMA/CHMP/CVMP/SWP/463311/2016 Graeme McKilligan, UK, MHRA. Content Intent of HBEL Post Implementation

More information

Why, How & What Digital Workplace

Why, How & What Digital Workplace Why, How & What Digital Workplace The Digital Workplace is the freedom to work as individuals and teams Anytime, Anyway, Anywhere Why commit to Digital Workplace transformation? Your digital workplace

More information

Factory of the future, enabling KETs. Advanced Manufacturing Systems as transversal KET. Speaker: Paolo Calefati Prima Industrie SpA

Factory of the future, enabling KETs. Advanced Manufacturing Systems as transversal KET. Speaker: Paolo Calefati Prima Industrie SpA Factory of the future, enabling KETs. Advanced Manufacturing Systems as transversal KET Speaker: Paolo Calefati Prima Industrie SpA EFFRA: Who We Are Representing Factories of the Future Established by

More information

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Title: Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Author:

More information

EUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020

EUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020 EUROPE 2020 17-19 March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA,

More information

1 What is Standardization? 2 What is a standard? 3 The Spanish Association for Standardization, UNE

1 What is Standardization? 2 What is a standard? 3 The Spanish Association for Standardization, UNE 1 What is Standardization? 2 What is a standard? 3 The Spanish Association for Standardization, UNE 3 4 UNE and European and international standardization 5 How are standards prepared? 6 Why participate?

More information